Grifols’ Biotest has received its first regulatory approval for a [...]
Grifols has expanded its portfolio of plasma-derived therapies in the [...]
Grifols’ Biotest has received its first regulatory approval for a [...]
Grifols has expanded its portfolio of plasma-derived therapies in the [...]